Literature DB >> 14682495

Molecular and genetic mechanisms of osteoporosis: implication for treatment.

H Shen1, R R Recker, H W Deng.   

Abstract

Osteoporosis is a leading public health problem in our rapidly growing, aging population. It is characterized by reduced bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture risk. Osteoporosis is a complex multifactorial disease, determined by genetic and environmental factors as well as their interactions. A large number of molecular, genetic and environmental factors underlying osteoporosis have been identified in past decades. In this article, we review 1) the molecular mechanisms of several principal systemic and local factors regulating bone metabolism; and 2) the current status of genetic studies searching for genes underlying osteoporosis. Further, we attempt to integrate knowledge from those two fields, and their potential implications for osteoporosis treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682495     DOI: 10.2174/1566524033479375

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  10 in total

1.  Correlation of transmenopausal bone mass in healthy white women: a long-term longitudinal study.

Authors:  L-J Zhao; P-Y Liu; R Recker; H-W Deng
Journal:  Osteoporos Int       Date:  2006-07-29       Impact factor: 4.507

Review 2.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

3.  Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Authors:  Irene Lambrinoudaki; George Christodoulakos; Leon Aravantinos; Aristidis Antoniou; Demetrios Rizos; Constantinos Chondros; Apostolos Kountouris; Grigorios Chrysofakis; George Creatsas
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  A Polymorphism in a gene encoding Perilipin 4 is associated with height but not with bone measures in individuals from the Framingham Osteoporosis Study.

Authors:  Natalie E Cusano; Douglas P Kiel; Serkalem Demissie; David Karasik; L Adrienne Cupples; Dolores Corella; Qiong Gao; Kris Richardson; Nikos Yiannakouris; Jose M Ordovas
Journal:  Calcif Tissue Int       Date:  2011-12-31       Impact factor: 4.333

Review 5.  Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?

Authors:  Mary H Hohenhaus; Kelly A McGarry; Nananda F Col
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Genotypes and clinical aspects associated with bone mineral density in Argentine postmenopausal women.

Authors:  Adriana Pérez; María Ulla; Beatriz García; María Lavezzo; Eliana Elías; Miriam Binci; María Rivoira; Viviana Centeno; Arturo Alisio; Nori Tolosa de Talamoni
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

7.  Refined QTLs of osteoporosis-related traits by linkage analysis with genome-wide SNPs: Framingham SHARe.

Authors:  David Karasik; Josée Dupuis; Kelly Cho; L Adrienne Cupples; Yanhua Zhou; Douglas P Kiel; Serkalem Demissie
Journal:  Bone       Date:  2010-01-11       Impact factor: 4.398

Review 8.  The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort.

Authors:  P F Giampietro; C McCarty; B Mukesh; F McKiernan; D Wilson; A Shuldiner; J Liu; J LeVasseur; L Ivacic; T Kitchner; N Ghebranious
Journal:  Osteoporos Int       Date:  2009-06-09       Impact factor: 4.507

9.  Genome-wide association with bone mass and geometry in the Framingham Heart Study.

Authors:  Douglas P Kiel; Serkalem Demissie; Josée Dupuis; Kathryn L Lunetta; Joanne M Murabito; David Karasik
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

10.  Type III collagen regulates osteoblastogenesis and the quantity of trabecular bone.

Authors:  Susan W Volk; Shalin R Shah; Arthur J Cohen; Yanjian Wang; Becky K Brisson; Laurie K Vogel; Kurt D Hankenson; Sherrill L Adams
Journal:  Calcif Tissue Int       Date:  2014-03-14       Impact factor: 4.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.